Prot# MAD103894: A 28 Day, Polysomnographic and Subjective Assessment of GW679769, 10 and 30mg, for the Treatment of Primary Insomnia: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial

Project: Research project

Project Details

StatusFinished
Effective start/end date11/18/05 → 3/11/08

Funding

  • PPD Development (MAD103894 // MAD103894)
  • GlaxoSmithKline plc (MAD103894 // MAD103894)